Chronic Respiratory Disease costs the world $3.89 trillion annually. We use Digital Twin technology to predict exacerbations 48 hours before they happen.
Current standards of care rely on lagging indicators. Patients are told to call a doctor when they feel "short of breath."
The Reality: By the time symptoms appear, physiological reserves are often exhausted. This is Silent Hypoxia—a decoupling of physiology and perception that leads to emergency hospitalization.
Traditional monitoring misses the drop in oxygen saturation (SaO2) because the patient feels no distress.
We move from reactive crisis management to predictive physiological modeling.
We don't just compare you to population averages. Our AI learns your specific respiratory "normal" to detect subtle deviations.
We combine passive biometric data from consumer wearables with proprietary breath analysis to model lung efficiency.
Our algorithms identify the signature of deterioration days in advance, providing the one thing patients need most: Time.
PulmoTwin utilizes a hybrid sensor-fusion approach. We integrate widely available consumer health data with advanced gas sensing technology to analyze Volatile Organic Compounds (VOCs) in the breath.
Development supported by: